A detailed history of Met Life Investment Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,346 shares of RGEN stock, worth $4.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
27,346
Previous 27,800 1.63%
Holding current value
$4.54 Million
Previous $3.5 Million 16.12%
% of portfolio
0.02%
Previous 0.02%

Shares

70 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.79 - $167.35 $54,384 - $75,976
-454 Reduced 1.63%
27,346 $4.07 Million
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $217,200 - $331,139
-1,810 Reduced 6.11%
27,800 $3.5 Million
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $5.06 Million - $6.17 Million
29,610 New
29,610 $5.45 Million
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $51,490 - $83,592
-451 Reduced 1.46%
30,360 $5.46 Million
Q3 2023

May 09, 2024

SELL
$138.78 - $176.51 $347,088 - $441,451
-2,501 Reduced 7.51%
30,811 $4.9 Million
Q3 2023

Apr 29, 2024

SELL
$138.78 - $176.51 $182,773 - $232,463
-1,317 Reduced 4.1%
30,811 $4.9 Million
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $182,773 - $232,463
-1,317 Reduced 4.1%
30,811 $4.9 Million
Q2 2023

Apr 29, 2024

BUY
$138.42 - $180.31 $4.45 Million - $5.79 Million
32,128 New
32,128 $4.54 Million
Q2 2023

Aug 10, 2023

SELL
$138.42 - $180.31 $163,889 - $213,487
-1,184 Reduced 3.55%
32,128 $4.54 Million
Q1 2023

May 09, 2024

BUY
$154.26 - $198.1 $5.14 Million - $6.6 Million
33,312 New
33,312 $5.61 Billion
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $129,886 - $166,800
-842 Reduced 2.47%
33,312 $5.61 Million
Q4 2022

May 10, 2024

SELL
$162.42 - $220.56 $113,531 - $154,171
-699 Reduced 2.01%
34,154 $5.78 Million
Q4 2022

Jun 14, 2023

BUY
$162.42 - $220.56 $136,757 - $185,711
842 Added 2.53%
34,154 $5.78 Million
Q4 2022

Mar 22, 2023

SELL
$162.42 - $220.56 $113,531 - $154,171
-699 Reduced 2.01%
34,154 $5.78 Million
Q4 2022

Feb 15, 2023

SELL
$162.42 - $220.56 $113,531 - $154,171
-699 Reduced 2.01%
34,154 $5.78 Million
Q3 2022

May 10, 2024

SELL
$160.42 - $256.21 $58,392 - $93,260
-364 Reduced 1.03%
34,853 $6.52 Million
Q3 2022

Jun 14, 2023

BUY
$160.42 - $256.21 $247,207 - $394,819
1,541 Added 4.63%
34,853 $6.52 Million
Q3 2022

Mar 22, 2023

SELL
$160.42 - $256.21 $58,392 - $93,260
-364 Reduced 1.03%
34,853 $6.52 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $58,392 - $93,260
-364 Reduced 1.03%
34,853 $6.52 Million
Q2 2022

May 10, 2024

SELL
$140.68 - $188.02 $57,397 - $76,712
-408 Reduced 1.15%
35,217 $5.72 Million
Q2 2022

Jun 20, 2023

BUY
$140.68 - $188.02 $267,995 - $358,178
1,905 Added 5.72%
35,217 $5.72 Million
Q2 2022

Mar 22, 2023

SELL
$140.68 - $188.02 $57,397 - $76,712
-408 Reduced 1.15%
35,217 $5.72 Million
Q2 2022

Aug 11, 2022

SELL
$140.68 - $188.02 $57,397 - $76,712
-408 Reduced 1.15%
35,217 $5.72 Million
Q1 2022

May 10, 2024

BUY
$161.19 - $257.96 $5.74 Million - $9.19 Million
35,625 New
35,625 $6.7 Million
Q1 2022

Jun 20, 2023

BUY
$161.19 - $257.96 $372,832 - $596,661
2,313 Added 6.94%
35,625 $6.7 Million
Q1 2022

Mar 22, 2023

BUY
$161.19 - $257.96 $1.73 Million - $2.76 Million
10,707 Added 42.97%
35,625 $6.7 Million
Q1 2022

May 12, 2022

BUY
$161.19 - $257.96 $1.73 Million - $2.76 Million
10,707 Added 42.97%
35,625 $6.7 Million
Q4 2021

May 17, 2024

BUY
$247.59 - $304.47 $87,894 - $108,086
355 Added 1.45%
24,918 $6.6 Million
Q4 2021

Jun 21, 2023

SELL
$247.59 - $304.47 $2.08 Million - $2.56 Million
-8,394 Reduced 25.2%
24,918 $6.6 Million
Q4 2021

Mar 22, 2023

BUY
$247.59 - $304.47 $72,296 - $88,905
292 Added 1.19%
24,918 $6.6 Million
Q4 2021

Feb 15, 2022

BUY
$247.59 - $304.47 $72,296 - $88,905
292 Added 1.19%
24,918 $6.6 Million
Q3 2021

May 17, 2024

SELL
$194.77 - $324.21 $185,226 - $308,323
-951 Reduced 3.73%
24,563 $7.1 Million
Q3 2021

Jun 21, 2023

SELL
$194.77 - $324.21 $1.7 Million - $2.84 Million
-8,749 Reduced 26.26%
24,563 $7.1 Million
Q3 2021

Mar 22, 2023

SELL
$194.77 - $324.21 $172,955 - $287,898
-888 Reduced 3.48%
24,626 $7.12 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $172,955 - $287,898
-888 Reduced 3.48%
24,626 $7.12 Million
Q2 2021

May 17, 2024

SELL
$165.87 - $220.95 $132,198 - $176,097
-797 Reduced 3.03%
25,514 $5.09 Million
Q2 2021

Jun 21, 2023

SELL
$165.87 - $220.95 $1.29 Million - $1.72 Million
-7,798 Reduced 23.41%
25,514 $5.09 Million
Q2 2021

Mar 22, 2023

SELL
$165.87 - $220.95 $132,198 - $176,097
-797 Reduced 3.03%
25,514 $5.09 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $132,198 - $176,097
-797 Reduced 3.03%
25,514 $5.09 Million
Q1 2021

May 17, 2024

SELL
$180.37 - $226.26 $595,040 - $746,431
-3,299 Reduced 11.14%
26,311 $5.12 Million
Q1 2021

Jun 26, 2023

SELL
$180.37 - $226.26 $1.26 Million - $1.58 Million
-7,001 Reduced 21.02%
26,311 $5.12 Billion
Q1 2021

Mar 22, 2023

SELL
$180.37 - $226.26 $222,035 - $278,526
-1,231 Reduced 4.47%
26,311 $5.12 Million
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $222,035 - $278,526
-1,231 Reduced 4.47%
26,311 $5.12 Million
Q4 2020

May 24, 2024

SELL
$148.08 - $206.57 $61,305 - $85,519
-414 Reduced 1.48%
27,542 $5.28 Million
Q4 2020

Jun 22, 2023

SELL
$148.08 - $206.57 $854,421 - $1.19 Million
-5,770 Reduced 17.32%
27,542 $5.28 Million
Q4 2020

Mar 22, 2023

SELL
$148.08 - $206.57 $61,305 - $85,519
-414 Reduced 1.48%
27,542 $5.28 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $61,305 - $85,519
-414 Reduced 1.48%
27,542 $5.28 Million
Q3 2020

Jun 26, 2023

SELL
$122.51 - $158.27 $656,163 - $847,694
-5,356 Reduced 16.08%
27,956 $4.12 Million
Q2 2020

May 24, 2024

SELL
$94.33 - $140.48 $156,021 - $232,353
-1,654 Reduced 5.59%
27,956 $3.46 Billion
Q2 2020

Jun 26, 2023

SELL
$94.33 - $140.48 $505,231 - $752,410
-5,356 Reduced 16.08%
27,956 $3.46 Million
Q2 2020

Mar 22, 2023

SELL
$94.33 - $140.48 $1.96 Million - $2.92 Million
-20,801 Reduced 42.66%
27,956 $3.46 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $1.96 Million - $2.92 Million
-20,801 Reduced 42.66%
27,956 $3.46 Million
Q1 2020

Jul 12, 2023

BUY
$84.96 - $109.14 $1.31 Million - $1.69 Million
15,445 Added 46.36%
48,757 $4.71 Million
Q1 2020

Mar 22, 2023

SELL
$84.96 - $109.14 $59,981 - $77,052
-706 Reduced 1.43%
48,757 $4.71 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $59,981 - $77,052
-706 Reduced 1.43%
48,757 $4.71 Million
Q4 2019

Jul 12, 2023

BUY
$73.84 - $93.08 $1.19 Million - $1.5 Million
16,151 Added 48.48%
49,463 $4.58 Million
Q4 2019

Mar 22, 2023

SELL
$73.84 - $93.08 $5,981 - $7,539
-81 Reduced 0.16%
49,463 $4.58 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $5,981 - $7,539
-81 Reduced 0.16%
49,463 $4.58 Million
Q3 2019

Jul 12, 2023

BUY
$76.65 - $95.51 $1.24 Million - $1.55 Million
16,232 Added 48.73%
49,544 $3.8 Million
Q3 2019

Mar 22, 2023

BUY
$76.65 - $95.51 $2.45 Million - $3.05 Million
31,946 Added 181.53%
49,544 $3.8 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $2.45 Million - $3.05 Million
31,946 Added 181.53%
49,544 $3.8 Million
Q2 2019

Jul 12, 2023

SELL
$54.2 - $85.95 $657,771 - $1.04 Million
-12,136 Reduced 36.43%
21,176 $1.82 Million
Q1 2019

Jul 13, 2023

SELL
$49.45 - $62.8 $777,057 - $986,839
-15,714 Reduced 47.17%
17,598 $1.04 Million
Q4 2018

Jul 13, 2023

SELL
$48.26 - $68.88 $758,357 - $1.08 Million
-15,714 Reduced 47.17%
17,598 $928,000
Q4 2018

Mar 22, 2023

SELL
$48.26 - $68.88 $471,017 - $672,268
-9,760 Reduced 35.68%
17,598 $928,000
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $471,017 - $672,268
-9,760 Reduced 35.68%
17,598 $928,000
Q3 2018

Jul 13, 2023

SELL
$46.8 - $58.97 $735,415 - $926,654
-15,714 Reduced 47.17%
17,598 $975,000
Q3 2018

Mar 22, 2023

SELL
$46.8 - $58.97 $318,052 - $400,760
-6,796 Reduced 19.9%
27,358 $1.52 Million
Q3 2018

Nov 14, 2018

BUY
$46.8 - $58.97 $456,768 - $575,547
9,760 Added 55.46%
27,358 $1.52 Million
Q4 2017

Feb 15, 2018

BUY
$32.53 - $38.92 $572,462 - $684,914
17,598
17,598 $638,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.